BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 31741175)

  • 1. Investigating the route of administration and efficacy of adipose tissue-derived mesenchymal stem cells and conditioned medium in type 1 diabetic mice.
    Hashemi SM; Hassan ZM; Hossein-Khannazer N; Pourfathollah AA; Soudi S
    Inflammopharmacology; 2020 Apr; 28(2):585-601. PubMed ID: 31741175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic efficacy and biodistribution of allogeneic mesenchymal stem cells delivered by intrasplenic and intrapancreatic routes in streptozotocin-induced diabetic mice.
    Yaochite JN; Caliari-Oliveira C; de Souza LE; Neto LS; Palma PV; Covas DT; Malmegrim KC; Voltarelli JC; Donadi EA
    Stem Cell Res Ther; 2015 Mar; 6(1):31. PubMed ID: 25884215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple intravenous infusions of bone marrow mesenchymal stem cells reverse hyperglycemia in experimental type 2 diabetes rats.
    Hao H; Liu J; Shen J; Zhao Y; Liu H; Hou Q; Tong C; Ti D; Dong L; Cheng Y; Mu Y; Liu J; Fu X; Han W
    Biochem Biophys Res Commun; 2013 Jul; 436(3):418-23. PubMed ID: 23770360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous vs intraperitoneal mesenchymal stem cells administration: what is the best route for treating experimental colitis?
    Gonçalves Fda C; Schneider N; Pinto FO; Meyer FS; Visioli F; Pfaffenseller B; Lopez PL; Passos EP; Cirne-Lima EO; Meurer L; Paz AH
    World J Gastroenterol; 2014 Dec; 20(48):18228-39. PubMed ID: 25561790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous Infusion of Human Adipose Tissue-Derived Mesenchymal Stem Cells to Treat Type 1 Diabetic Mellitus in Mice: An Evaluation of Grafted Cell Doses.
    Dang LT; Bui AN; Le-Thanh Nguyen C; Truong NC; Bui AT; Kim NP; Truong KD; Van Pham P
    Adv Exp Med Biol; 2018; 1083():145-156. PubMed ID: 29423674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of in vivo immunomodulatory effects of intravenous and intraperitoneal administration of adipose-tissue mesenchymal stem cells in experimental autoimmune encephalomyelitis (EAE).
    Yousefi F; Ebtekar M; Soleimani M; Soudi S; Hashemi SM
    Int Immunopharmacol; 2013 Nov; 17(3):608-16. PubMed ID: 23973288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adipose tissue-derived mesenchymal stem cells exert in vitro immunomodulatory and beta cell protective functions in streptozotocin-induced diabetic mice model.
    Rahavi H; Hashemi SM; Soleimani M; Mohammadi J; Tajik N
    J Diabetes Res; 2015; 2015():878535. PubMed ID: 25893202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decitabine assists umbilical cord-derived mesenchymal stem cells in improving glucose homeostasis by modulating macrophage polarization in type 2 diabetic mice.
    Gao J; Cheng Y; Hao H; Yin Y; Xue J; Zhang Q; Li L; Liu J; Xie Z; Yu S; Li B; Han W; Mu Y
    Stem Cell Res Ther; 2019 Aug; 10(1):259. PubMed ID: 31426846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGF-β engineered mesenchymal stem cells (TGF-β/MSCs) for treatment of Type 1 diabetes (T1D) mice model.
    Daneshmandi S; Karimi MH; Pourfathollah AA
    Int Immunopharmacol; 2017 Mar; 44():191-196. PubMed ID: 28110219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infusion with Human Bone Marrow-derived Mesenchymal Stem Cells Improves β-cell Function in Patients and Non-obese Mice with Severe Diabetes.
    Li L; Hui H; Jia X; Zhang J; Liu Y; Xu Q; Zhu D
    Sci Rep; 2016 Dec; 6():37894. PubMed ID: 27905403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous vs intraperitoneal transplantation of umbilical cord mesenchymal stem cells from Wharton's jelly in the treatment of streptozotocin-induced diabetic rats.
    El-Hossary N; Hassanein H; El-Ghareeb AW; Issa H
    Diabetes Res Clin Pract; 2016 Nov; 121():102-111. PubMed ID: 27693839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrapancreatic MSC transplantation facilitates pancreatic islet regeneration.
    Khatri R; Petry SF; Linn T
    Stem Cell Res Ther; 2021 Feb; 12(1):121. PubMed ID: 33579357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of marginal mass required for successful islet transplantation in a diabetic rat model using adipose tissue-derived mesenchymal stromal cells.
    Navaei-Nigjeh M; Moloudizargari M; Baeeri M; Gholami M; Lotfibakhshaiesh N; Soleimani M; Vasheghani-Farahani E; Ai J; Abdollahi M
    Cytotherapy; 2018 Sep; 20(9):1124-1142. PubMed ID: 30068495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosomes Secreted by Umbilical Cord Blood-Derived Mesenchymal Stem Cell Attenuate Diabetes in Mice.
    Sharma R; Kumari M; Mishra S; Chaudhary DK; Kumar A; Avni B; Tiwari S
    J Diabetes Res; 2021; 2021():9534574. PubMed ID: 34926699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amelioration of diabetic nephropathy in mice by a single intravenous injection of human mesenchymal stromal cells at early and later disease stages is associated with restoration of autophagy.
    He J; Liu B; Du X; Wei Y; Kong D; Feng B; Guo R; Asiamah EA; Griffin MD; Hynes SO; Shen S; Liu Y; Cui H; Ma J; O'Brien T
    Stem Cell Res Ther; 2024 Mar; 15(1):66. PubMed ID: 38443965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multipotent mesenchymal stromal cells from patients with newly diagnosed type 1 diabetes mellitus exhibit preserved in vitro and in vivo immunomodulatory properties.
    Yaochite JN; de Lima KW; Caliari-Oliveira C; Palma PV; Couri CE; Simões BP; Covas DT; Voltarelli JC; Oliveira MC; Donadi EA; Malmegrim KC
    Stem Cell Res Ther; 2016 Jan; 7():14. PubMed ID: 26781648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple intravenous transplantations of mesenchymal stem cells effectively restore long-term blood glucose homeostasis by hepatic engraftment and β-cell differentiation in streptozocin-induced diabetic mice.
    Ho JH; Tseng TC; Ma WH; Ong WK; Chen YF; Chen MH; Lin MW; Hong CY; Lee OK
    Cell Transplant; 2012; 21(5):997-1009. PubMed ID: 22004871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Undifferentiated Wharton's Jelly Mesenchymal Stem Cell Transplantation Induces Insulin-Producing Cell Differentiation and Suppression of T-Cell-Mediated Autoimmunity in Nonobese Diabetic Mice.
    Tsai PJ; Wang HS; Lin GJ; Chou SC; Chu TH; Chuan WT; Lu YJ; Weng ZC; Su CH; Hsieh PS; Sytwu HK; Lin CH; Chen TH; Shyu JF
    Cell Transplant; 2015; 24(8):1555-70. PubMed ID: 25198179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulatory and protective effects of adipose tissue-derived mesenchymal stem cells in an allograft islet composite transplantation for experimental autoimmune type 1 diabetes.
    Mohammadi Ayenehdeh J; Niknam B; Rasouli S; Hashemi SM; Rahavi H; Rezaei N; Soleimani M; Liaeiha A; Niknam MH; Tajik N
    Immunol Lett; 2017 Aug; 188():21-31. PubMed ID: 28506774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo immunomodulatory effects of adipose-derived mesenchymal stem cells conditioned medium in experimental autoimmune encephalomyelitis.
    Yousefi F; Ebtekar M; Soudi S; Soleimani M; Hashemi SM
    Immunol Lett; 2016 Apr; 172():94-105. PubMed ID: 26930038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.